biopharmaceutical

(redirected from biopharmaceuticals)
Also found in: Medical.

bi·o·phar·ma·ceu·ti·cal

 (bī′ō-fär′mə-so͞o′tĭ-kəl)
n.
A drug produced by means of biotechnology, consisting of a large, complex molecule such as a protein rather than a small molecule.
adj.
1. Of or relating to a drug or drugs produced by means of biotechnology: the biopharmaceutical industry.
2. Of or relating to properties of pharmaceutical preparations and their effects after administration: biopharmaceutical factors affecting intestinal absorption of the drug.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

biopharmaceutical

(ˌbaɪəʊˌfɑːməˈsjuːtɪkəl)
adj
(Biochemistry) of or relating to drugs produced using biotechnology
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations

biopharmaceutical

n biológico, biofármaco
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
SECTION 1: INTRODUCTION TO ADVANCES IN CHINA BIOPHARMACEUTICALS
ENPNewswire-July 31, 2019--Alder BioPharmaceuticals to Host Conference Call to Discuss Second Quarter 2019 Financial and Operating Results
Oulu, Finland, May 07, 2019 --(PR.com)-- Paras Biopharmaceuticals Finland Oy is proud to announce that Reuters.com / Reuters Plus has selected the Finland-based company, working on biologics manufacturing & innovations in the healthcare segment as a valued contributor to the future of healthcare solutions.
M2 PHARMA-April 22, 2019-SK Biopharmaceuticals and twoXAR Team to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer
M2 EQUITYBITES-April 19, 2019-SK Biopharmaceuticals collaborates with twoXAR
The United States is the largest market for biopharmaceuticals, accounting for around a third of the global market, and is the world leader in biopharmaceutical R&D.
Global Banking News-February 14, 2019-Arvelle Therapeutics acquires exclusive rights to develop and commercialise Cenobamate in Europe from SK Biopharmaceuticals
The changes will create therapy area-focused Research and Development units that are responsible for discovery through to late-stage development - one for BioPharmaceuticals - Cardiovascular, Renal & Metabolism and Respiratory - and one for Oncology, with dynamic resource allocation across the company's pipeline.
21 August 2018 - French virus-based immunotherapies developer Transgene (PAR: TNG) has closed transactions signed with Chinese drugmaker Tasly Biopharmaceuticals. Co.
There is a "huge market opportunity for any company" that can reduce the cost of biosimilars within the biopharmaceutical market," says Mordor Intelligence's new report, "Global Biopharmaceuticals Market Growth, Trends & Forecasts (2017-2022)."